Shigemitsu Takashima
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Surgery top 10%
- Cancer Research top 5%
- Co-authors
- Kenjiro AogiAkira KuritaHideyuki SaekiMasao NakataShozo OhsumiKenji EguchiToshiaki SaekiToru Watanabe
- Topics
- Cancer Treatment and Pharmacology (37 papers)Breast Cancer Treatment Studies (33 papers)Metastasis and carcinoma case studies (15 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Shigemitsu Takashima
143 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 121
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.1k
- Radiology, Nuclear Medicine and Imaging 640
- Surgery 497
- Cancer Research 489
Countries citing papers authored by Shigemitsu Takashima
This map shows the geographic impact of Shigemitsu Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigemitsu Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigemitsu Takashima more than expected).
Fields of papers citing papers by Shigemitsu Takashima
This network shows the impact of papers produced by Shigemitsu Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigemitsu Takashima. The network helps show where Shigemitsu Takashima may publish in the future.
Co-authorship network of co-authors of Shigemitsu Takashima
This figure shows the co-authorship network connecting the top 25 collaborators of Shigemitsu Takashima. A scholar is included among the top collaborators of Shigemitsu Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigemitsu Takashima. Shigemitsu Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 9 | |
| 3 | 29 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia. | 4 |
| 10 | 4 | |
| 11 | 154 | |
| 12 | 5 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 4 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 3 |
About Shigemitsu Takashima
Shigemitsu Takashima is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 158 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (37 papers), Breast Cancer Treatment Studies (33 papers) and Metastasis and carcinoma case studies (15 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Complementary and alternative medicine (268 citations). Shigemitsu Takashima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kenjiro Aogi, Akira Kurita, Hideyuki Saeki, Masao Nakata, Shozo Ohsumi, Kenji Eguchi, Toshiaki Saeki, Toru Watanabe, Shigeki Sawada and Yasuo Ohashi. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.